Table 12: Subjective Measures of Effectiveness, Visual Laser Ablation Versus Transurethral Resection of the Prostate.
| Study, Year | IPSS, Mean (SD) | QOL score, Mean (SD) | ||
|---|---|---|---|---|
| Baseline | 7.5 months | Baseline | 7.5 months | |
| Chacko et al. 2001(67) VLAP TURP |
17.6 (9.3) 19.4 (7.6) |
Mean change in quantitative scores (95% CI) ™10.06 (™12.80 to ™7.31) 13.52 (™15.81 to ™11.23) P =.26 Categorical version * Adjusted OR (95% CI): 2.14 (0.81–5.65) P =.12 |
Median 5 (4.6) 5 (4.6) |
Mean change (95% CI) -3.10 (-3.65 to -2.55) -3.42 (-3.89 to -2.95) |
| Gujral et al. 2000 (68) VLAP TURP |
20.9 (6.4) 19.5 97.2) |
Mean change in quantitative scores (95% CI) -12.2 (-15.7 to -8.7) -14.2 (-17.2 to -11.2) P = .048 Categorical version* Adjusted OR (95% CI): 3.9 (1−14.3) Favour TURP |
Median 5 (2.6) 4.5 (2.6) |
Mean change (95% CI) -2.8 (-3.4 to -2.1) -3.2 (-3.9 to -2.6) P = .97 |
| Donovan et al. 2000 (69) VLAP TURP |
19.2 (6.7) 19.1 (6.6) |
Mean change in quantitative scores (95% CI) -10.8 (-12.5 to -9) -12.3 (-13.8 to -10.7) P >.05 Categorical version* OR (95% CI): 2.4 (1.2–4.6) P <.05 Favour TURP |
Median 4 4 |
Mean change (95% CI) -1.9 (-2.3 to -1.6) -2.2 (-2.5 to -1.8) |
*
Categories of good, moderate, poor
IPSS refers to International Prostate Symptom Score; NR, not reported; QOL, quality of life; SD, standard deviation; TURP, transurethral resection of the prostate; VLAP, visual laser ablation of the prostate